News

Caris Life Sciences shares ended trading at $28 per share on Wednesday, marking a 33% increase from its initial public offering (IPO) price of $21 per share.
Recent health news highlights include global bird flu restrictions impacting Brazilian chicken exports, advancements in ...
Shares of Caris Life Sciences soared in their public debut Wednesday, as investors bought into the company’s business of ...
The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...
New listings in the U.S. have bounced back sharply in recent weeks, with some eye-popping debuts stoking hopes of a sustained ...